Authors:
ADAMI S
PASSERI M
ORTOLANI S
BROGGINI M
CARRATELLI L
CARUSO I
GANDOLINI G
GNESSI L
LAURENZI M
LOMBARDI A
NORBIATO G
PRYORTILLOTSON S
REDA C
ROMANINI L
SUBRIZI D
WEI L
YATES AJ
Citation: S. Adami et al., EFFECTS OF ORAL ALENDRONATE AND INTRANASAL SALMON-CALCITONIN ON BONE MASS AND BIOCHEMICAL MARKERS OF BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS, Bone, 17(4), 1995, pp. 383-390
Authors:
PORRECA E
REALE M
DIFEBBO C
BARBACANE RC
CASTELLANI ML
CIPOLLONE F
CARRATELLI L
CONTI P
CUCCURULLO F
Citation: E. Porreca et al., EFFECT OF MK-571, A SELECTIVE LEUKOTRIENE D-4 RECEPTOR ANTAGONIST, ONVASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND INTERLEUKIN-1 RELEASE, International journal of immunopathology and pharmacology, 7(1), 1994, pp. 57-64
Authors:
ADAMI S
BARONI MC
BROGGINI M
CARRATELLI L
CARUSO I
GNESSI L
LAURENZI M
LOMBARDI A
NORBIATO G
ORTOLANI S
RICERCA E
ROMANINI L
SUBRIZI S
WEINBERG J
YATES AJ
Citation: S. Adami et al., TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH CONTINUOUS DAILY ORAL ALENDRONATE IN COMPARISON WITH EITHER PLACEBO OR INTRANASAL SALMON-CALCITONIN, Osteoporosis international, 3, 1993, pp. 190000021-190000027